Literature DB >> 35999415

Transgender and Non-binary Persons in Contemporary Oncology Randomized Clinical Trials.

Enrique O Martinez1, Micah Rubin1, Tessa Miller1, Chandler S Cortina2,3,4.   

Abstract

Entities:  

Year:  2022        PMID： 35999415     DOI： 10.1245/s10434-022-12418-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  5 in total

1.  Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples.

Authors:  Esther L Meerwijk; Jae M Sevelius
Journal:  Am J Public Health       Date:  2017-02       Impact factor: 9.308

2.  Inclusion and Reporting of Transgender and Nonbinary Persons in Clinical Trials and Tumor Registries-The Time Is Now.

Authors:  Chandler S Cortina
Journal:  JAMA Oncol       Date:  2022-08-01       Impact factor: 33.006

3.  Testosterone therapy and risk of breast cancer development: a systematic review.

Authors:  Al Ray; Austin Fernstrum; Amr Mahran; Nannan Thirumavalavan
Journal:  Curr Opin Urol       Date:  2020-05       Impact factor: 2.309

4.  Disparities in Cancer Care: Educational Initiatives.

Authors:  Monica Morrow; Lisa A Newman
Journal:  Ann Surg Oncol       Date:  2022-01-31       Impact factor: 4.339

Review 5.  Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care.

Authors:  Callisia N Clarke; Chandler S Cortina; Oluwadamilola M Fayanju; Lesly A Dossett; Fabian M Johnston; Sandra L Wong
Journal:  Ann Surg Oncol       Date:  2021-06-07       Impact factor: 5.344
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.